A
Arterys
Health Tech & Medtech · San Francisco, United States · Founded 2013
Medical Imaging Cloud Platform MoreLess
Arterys operates in the healthcare sector, specializing in medical imaging enhanced by artificial intelligence (AI). The company serves healthcare providers, including hospitals and clinics, by integrating AI-driven clinical applications into existing Picture Archiving and Communication Systems (PACS) or Electronic Health Records (EHR) workflows. This integration allows for seamless adoption of advanced diagnostic tools without disrupting current practices. Arterys' platform is cloud-based, ensuring accessibility from any validated device, which enhances performance and deployment ease while maintaining data security. The business model revolves around a subscription-based service, where clients pay for access to the AI tools and platform. Revenue is generated through these subscriptions and potentially through partnerships with other healthcare technology providers. The platform's key features include improved diagnostic accuracy, enhanced physician experience, and better financial performance for healthcare providers. Arterys aims to transform healthcare by leveraging deep learning and AI to extract actionable insights from medical images, thereby improving clinical decision-making, efficiency, and productivity.
Keywords: medical imaging, AI, healthcare, diagnostics, PACS, EHR, cloud-based, deep learning, clinical applications, physician workflow.
Company overview
Arterys company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2013
- Headquarters
- San Francisco, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 79.5
- Investment activity
- 1 companies · latest Nov 2017
- Capital deployed
- $30M
- Preferred round
- SERIES B
Valuation & funding
Arterys funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | May 2020 | $28M | $112M | Revelation Partners · Fosun Group · Varian Medical Systems · Emergent Medical Partners | ↗ |
| CONVERTIBLEOther financing | Jul 2019 | $0 | — | Asset Management Ventures | — |
| SERIES BOther financing | Nov 2017 | $30M | $120M | Varian Medical Systems · Arterys · ORI Capital · Emergent Medical Partners | — |
| GRANTOther financing | May 2017 | $0 | — | MedTech Innovator | — |
| SERIES AOther financing | Mar 2016 | $12M | $48M | AME Cloud Ventures · StartX · Morado Ventures · Emergent Medical Partners | — |
| SERIES AOther financing | Dec 2015 | AME Cloud Ventures · Emergent Medical Partners · Norwich Ventures · Asset Management Ventures | — | ||
| EARLY VCOther financing | Apr 2014 | GE Ventures | — | ||
| SPINOUTOther financing | Sep 2013 | Stanford University | — | ||
| SEEDOther financing | Jun 2013 | Asset Management Ventures · Farzad (Zod) Nazem | — | ||
| SEEDOther financing | Jan 2013 | Asset Management Ventures | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $8.6M | 0% | 14 |
| 2025 | $8.6M | 0% | 14 |
| 2024 | $8.6M | 0% | 15 |
| 2023 | $8.6M | 0% | 21 |
| 2022 | $8.6M | +9.4% | 63 |
| 2021 | $7.9M | -73.7% | 63 |
| 2020 | $30M | — | 63 |
Growth signals
Arterys website traffic
Latest recorded traffic for Arterys is 3.4K monthly website visits, up 9.7% over the last three months. Arterys's team grew 0% over the past year.
Comparisons
Arterys compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Arterys investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Arterys's talent
Source: Dealroom Talent Intelligence.
Investors
18 investors on Arterys's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.






Global footprint
Where Arterys has talent and traffic
team presence
In the news
Latest news about Arterys
Recent press, funding announcements, and product moves mentioning Arterys — open to read from the original sources.
Market sentiment
What the market is saying about Arterys
An AI-synthesized read of the highest-engagement posts about Arterys on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arterys’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.


















